The classic website will no longer be available as of June 25, 2024. Please use the modernized
Working… Menu

ONC-392 Plus Lutetium Lu 177 Vipivotide Tetraxetan in Patients With mCRPC (PRESERVE-006)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT05682443
Recruitment Status : Recruiting
First Posted : January 12, 2023
Last Update Posted : May 10, 2024
Prostate Cancer Clinical Trials Consortium
Information provided by (Responsible Party):
OncoC4, Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 30, 2026
Estimated Study Completion Date : June 30, 2027